Human GHRL/Ghrelin ELISA Kit

Référence ELH-GHRL-5

Conditionnement : 5PlateKit

Marque : RayBiotech

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

25% off all ELISA kits

Use code ELISA25-262 for 25% off all ELISAs through November.

Human GHRL/Ghrelin ELISA Kit

RayBio® Human Ghrelin ELISA Kit for Cell Culture Supernatants, Plasma, and Serum samples.

Lead time: Typically ships within 1-2 business days. No Friday shipments.

Contact Us for Bulk Request

Product Description

Specifications

Size1 Plate Kit, 2 Plate Kit, 5 Plate Kit
SpeciesHuman
Sensitivity
8 pg/ml.

Need more sensitivity? Check out the new NexaTag® kit for this target. Still not enough? Then your answer is our Ultrasensitive Biomarker Testing Service powered by Simoa™ technology.

Detection Range
8 pg/ml - 2000 pg/ml
Specificity
This ELISA antibody pair detects human GHRL/Ghrelin. Other species not determined.
Compatible Sample TypesCell Culture Supernatants, Plasma, Serum
Recommended Dilution (Serum/Plasma)
2 fold
Accession Number
Q9UBU3
Gene Id
51738
Gene Symbols
GHRL, MTLRP, UNQ524/PRO1066
Protein Name / Synonyms
Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27 Ghrelin-28 (Ghrelin) Obestatin]
Quantitative/Semi-QuantitativeQuantitative
Solid Support
96-well Microplate
Design PrincipleSandwich-based
Method Of DetectionColorimetric
Research AreaAngiogenesis, Cancer, Inflammation
Shipping TypeBlue ice
Storage≤-20°C

Product Features

Additional Notes
  • Strip plates and additional reagents allow for use in multiple experiments
  • Quantitative protein detection
  • Establishes normal range
  • The best products for confirmation of antibody array data

Standard Curves

Spiking & Recovery Results

Linearity Results

Application Notes

Kit Components
  • Pre-Coated 96-well Strip Microplate
  • Wash Buffer
  • Stop Solution
  • Assay Diluent(s)
  • Lyophilized Standard
  • Biotinylated Detection Antibody
  • Streptavidin-Conjugated HRP
  • TMB One-Step Substrate
Other Materials Required
  • Distilled or deionized water
  • Precision pipettes to deliver 2 µl to 1 µl volumes
  • Adjustable 1-25 µl pipettes for reagent preparation
  • 100 µl and 1 liter graduated cylinders
  • Tubes to prepare standard and sample dilutions
  • Absorbent paper
  • Microplate reader capable of measuring absorbance at 450nm
  • Log-log graph paper or computer and software for ELISA data analysis
Protocol Outline
  1. Prepare all reagents, samples and standards as instructed in the manual.
  2. Add 100 µl of standard or sample to each well.
  3. Incubate 2.5 h at RT or O/N at 4°C.
  4. Add 100 µl of prepared biotin antibody to each well.
  5. Incubate 1 h at RT.
  6. Add 100 µl of prepared Streptavidin solution to each well.
  7. Incubate 45 min at RT.
  8. Add 100 µl of TMB One-Step Substrate Reagent to each well.
  9. Incubate 30 min at RT.
  10. Add 50 µl of Stop Solution to each well.
  11. Read at 450 nm immediately.

Storage/Stability

The entire kit may be stored at -20°C for up to 1 year from the date of shipment. Avoid repeated freeze-thaw cycles. The kit may be stored at 4°C for up to 6 months. For extended storage, it is recommended to store at -80°C.

Customize This Human GHRL/Ghrelin ELISA

We manufacture our ELISAs in-house, so we can build a custom version for your study.

  • Post-translational modifications (PTMs): Detect modified Ghrelin (GHRL), including phosphorylation, acetylation, S-nitrosylation, S-acylation, oxidation, lactylation, sumoylation, ubiquitination, nitration, carbamylation, and more
  • Sample types: Validation in your matrix using samples you provide, such as CSF, urine, saliva, lysates, or exosomes
  • Also available: More sensitive platforms such as Simoa® and NexaTag®, multiplex panels, bulk lots, and other species when suitable reagents exist

Feasibility varies by target and modification, and we’ll tell you upfront what’s achievable.

Learn more about custom ELISA development

documents

Excel (Sandwich-ELISA-Analysis-Tool.xlsm)

citations

  • Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation

    Species:
    Human
    Sample Type:
    Plasma (fasting older adults, sarcopenia vs controls)
    Year:
    2024
    Journal Name:
    Journal of Cachexia Sarcopenia and Muscle
    PubMed ID:
    38926763
  • Cholecystokinin inhibits myotube fusion and may contribute to sarcopenia: Evidence from clinical and C2C12 myoblast studies

    Species:
    Human
    Sample Type:
    Serum
    Year:
    2026
    Journal Name:
    Journal of the Chinese Medical Association : JCMA
    PubMed ID:
    41430742
  • Blenderized watermelon consumption decreases body mass index, body mass index percentile, body fat and HbA1c in children with overweight or obesity

    Species:
    Human
    Sample Type:
    Serum
    Year:
    2023
    Journal Name:
    Pediatric Obesity
  • FTO genotypes (rs9939609 T>A) are Associated with Increased Added Sugar Intake in Healthy Young Adults

    Species:
    Human
    Sample Type:
    Serum
    Year:
    2023
    Journal Name:
    Lifestyle Genomics
  • Effects of Fresh Watermelon Consumption on the Acute Satiety Response and Cardiometabolic Risk Factors in Overweight and Obese Adults

    Species:
    Human
    Sample Type:
    Serum (overweight/obese adults, watermelon intervention)
    Year:
    2019
    Journal Name:
    Nutrients
    PubMed ID:
    30870970
  • Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population

    Species:
    Human
    Sample Type:
    Plasma (fasting; T2D cases and controls)
    Year:
    2020
    Journal Name:
    BMC endocrine disorders
    PubMed ID:
    32698854
  • Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

    Species:
    Human
    Sample Type:
    Whole Blood (T2D and obesity, GLP-1RA therapy)
    Year:
    2019
    Journal Name:
    Journal of Diabetes Research
    PubMed ID:
    30944827
  • Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study

    Species:
    Human
    Sample Type:
    Serum (patients’ stored serum samples)
    Year:
    2021
    Journal Name:
    PLoS ONE
    PubMed ID:
    34813621

Vous serez peut-être également intéressé par les produits suivants :



Référence
Description
Cond.
Prix HT
EIA-CCK-1
 1PlateKit 
EIA-CCK-2
 2PlateKit 
EIA-CCK-5
 5PlateKit